Lundbeck
HLUN-B.CO
#2346
Rank
S$8.51 B
Marketcap
$8.80
Share price
0.98%
Change (1 day)
20.12%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$2.97 B

According to Lundbeck 's latest financial reports the company's total liabilities are S$2.97 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lundbeck - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$3.00 B-6.65%
2022-12-31S$3.21 B-4.26%
2021-12-31S$3.36 B-19.27%
2020-12-31S$4.16 B-3.26%
2019-12-31S$4.30 B135.45%
2018-12-31S$1.82 B11.94%
2017-12-31S$1.63 B-24.21%
2016-12-31S$2.15 B-17.17%
2015-12-31S$2.60 B-0.45%
2014-12-31S$2.61 B9.56%
2013-12-31S$2.38 B31.43%
2012-12-31S$1.81 B3.7%
2011-12-31S$1.75 B10.57%
2010-12-31S$1.58 B-29.75%
2009-12-31S$2.25 B66.4%
2008-12-31S$1.35 B-6.91%
2007-12-31S$1.45 B9.95%
2006-12-31S$1.32 B21.33%
2005-12-31S$1.09 B10.69%
2004-12-31S$0.98 B